Trial Profile
A Randomised Clinical Trial Evaluating Adjuvant Chemotherapy With Capecitabine Compared to Expectant Treatment Alone (Observation) Following Surgery for Biliary Tract Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2023
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- Acronyms BILCAP
- 24 Oct 2023 Results assessing the impact of alterations in cancer driver genes and other potentially targetable mutations on progression and overall survival in patients with biliary tract cancer, presented at the 48th European Society for Medical Oncology Congress.
- 06 Jun 2023 Results assessing alterations in cancer driver genes and other potentially targetable mutations in patients with intrahepatic cholangiocarcinoma (iCCA), presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
- 22 Mar 2022 Results of Long-Term Outcomes and Exploratory Analyses published in the Journal of Clinical Oncology